Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.
Vojinović J, Foeldvari I, Dehoorne J, Panaviene V, Susic G, Horneff G, Stanevica V, Kobusinska K, Zuber Z, Dobrzyniecka B, Avcin T, Borlenghi C, Arthur E, Zang C, Tsekouras V, Vlahos B, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
Vojinović J, et al. Among authors: arthur e.
Rheumatol Ther. 2024 Dec;11(6):1437-1440. doi: 10.1007/s40744-024-00703-z. Epub 2024 Sep 12.
Rheumatol Ther. 2024.
PMID: 39264536
Free PMC article.